PSCI Member Digest February 2026
Get a quick update on the latest PSCI news, including the PSCI Principles Review, the PSCI Supplier Decarbonization Help Desk, webinars, new learning courses, and more.
Access our full library of resources, register for events and webinars and share audits and other assessments
Get a quick update on the latest PSCI news, including the PSCI Principles Review, the PSCI Supplier Decarbonization Help Desk, webinars, new learning courses, and more.
The ๐ฃ๐ฆ๐๐ ๐ฃ๐ฟ๐ถ๐ป๐ฐ๐ถ๐ฝ๐น๐ฒ๐ ๐ณ๐ผ๐ฟ ๐ฅ๐ฒ๐๐ฝ๐ผ๐ป๐๐ถ๐ฏ๐น๐ฒ ๐ฆ๐๐ฝ๐ฝ๐น๐ ๐๐ต๐ฎ๐ถ๐ป ๐ ๐ฎ๐ป๐ฎ๐ด๐ฒ๐บ๐ฒ๐ป๐ are our blueprint for responsible practice across the pharmaceutical and healthcare supply chain โ and we are now inviting external stakeholders to provide input to our latest round of updates.
๐๐ฏ๐ผ๐๐ ๐๐ต๐ฒ ๐ฃ๐ฟ๐ถ๐ป๐ฐ๐ถ๐ฝ๐น๐ฒ๐
The Principles sit above individual supplier codes, setting highโlevel expectations and encouraging members and suppliers to consider and respond to these topics within their own practices. They are designed to:
With this in mind, our challenge is finding the right level of stretch: continuing to drive progress toward PSCIโs vision of responsible supply chains, while ensuring the Principles remain achievable and universal.
We are now inviting external stakeholders to contribute to this update through our consultation survey
To maintain a substantial amount of consistency in the Principles, we ask that suggestions focus on up to ๐ผ๐ป๐ฒ ๐๐ถ๐ด๐ป๐ถ๐ณ๐ถ๐ฐ๐ฎ๐ป๐ ๐ฎ๐ป๐ฑ ๐๐ฝ ๐๐ผ ๐๐ต๐ฟ๐ฒ๐ฒ ๐บ๐ถ๐ป๐ผ๐ฟ ๐ฐ๐ต๐ฎ๐ป๐ด๐ฒ๐.
Further details on the process and timeline can be found here
The deadline for feedback is ๐ด ๐๐ฝ๐ฟ๐ถ๐น, and the final updated Principles will be published in ๐๐ฒ๐ฐ๐ฒ๐บ๐ฏ๐ฒ๐ฟ ๐ฎ๐ฌ๐ฎ๐ฒ.
We look forward to hearing your perspectives and shaping the next evolution of the PSCI Principles together.
Anne-Laure Demarcy, Head of Environmental Sustainability at UCB, will join the Board in a non-voting, one-year guest position, supporting a diversity of perspective in the PSCI's governance.
Speaking of her appointment Anne-Laure says,
I see this guest Board position as an opportunity to contribute meaningfully to the PSCI's mission, while bringing a diverse and pragmatic perspective.
Please join us in congratulating Anne-Laure on her appointment.
About the guest role
2026 PSCI Chair, Lucy Latham is expecting her second child in spring and
in accordance with the PSCI Bylaws, the Vice Chair and Chair will jointly cover the Chair role during Lucyโs absence. We thank Rob Williams and Peter Nestor for their support in this matter.
The PSCI Board agreed to open up one temporary guest position on the Board, in a non-voting role, intended to maintain diversity of perspective in PSCIโs governance, for a period of 12 months or until the Chair's return.
Get a quick update on the latest PSCI news, including the PSCI Principles Review & Future Audit Protocol Update, the PSCI Supplier Decarbonization Help Desk, webinars, new learning courses, and more.
The Energize program aims to increase access to renewable electricity for suppliers in the pharmaceutical industry. The program is growing and now has 26 global pharmaceutical companies working to support their suppliers to decarbonize and mitigate the overall environmental impact of the industry. Join Schneider Electric, Energize program manager, to learn more about the program and benefits of participating.
Agenda
What is Energize?
Why is Energize important?
Program Education
Renewable Electricity Procurement Support
Program Benefits
What to expect when you join the program and next steps
Choose your session
Wednesday 11 February
Thursday 12 February
About Energize
The Energize program is a supply chain renewables initiative designed and delivered by Schneider Electric Sustainability Business and endorsed by the PSCI.
Current Energize sponsors: Almirall, Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Charles River Laboratories, Chiesi Group, GSK, Haleon, Johnson & Johnson, Kenvue, Merck (known as MSD outside the United States and Canada), Merck KGaA, Darmstadt, Germany, Novartis, Novo Nordisk, Pfizer, Roche, Sandoz, Sanofi, Schott, Takeda, Teva, UHG, and UCB.
Get a quick update on the latest PSCI news. From the newly announced 2026 Board to the launch of the integrated online audit process, new learning courses, upcoming webinars, and more.
The PSCI extends our sincere gratitude to the Committee and Topic Team Leads for their outstanding contributions throughout 2025. We would like to thank the following Members whose leadership terms ended in 2025.
Sarah Turiano, Capability Committee.
Sarah has led the PSCIโs efforts on training and development for the last three years as Co-Chair of the Capability Committee. She played a pivotal role in shaping the PSCIโs approach to learning and development and oversaw the launch of the Learnster platform.
Enric Bosch, Projects Committee.
Enric helped set up the Projects Committee and act as its first Co-Lead. He established the processes and procedures for investments, ensuring good governance and oversight; while his focus on value and quality led to the endorsement of multiple projects aimed to create deep impact for suppliers.
Vicki Stone-Bjarup, Projects Committee. Following on from her tenure as PSCI Chair, Vicki supported the establishment of the Projects Committee and steered it through its first years as a new venture for the PSCI. Her leadership and enthusiasm for supporting high impact projects ensured achievement of the Committeeโs aims.
We would also like to congratulate Vincent Mignone, Environment Topic Team Co-Lead, and Li Liu, China Regional Team Co-Lead, as they transition to the PSCI Board.
Birgit Skuballa (Bayer) - Audit
Dorota Wiacek-Trojanowska (Roche) - Audit
Sarah Turiano (Viatris) - Capability
Wenjia Xu (Merck & Co) - Capability
Enric Bosch (Boehringer Ingelheim) - Projects
Vicki Stone-Bjarup (Novo Nordisk) - Projects
Pietro Butti (Roche) - Management Systems
Bridget Ferrari (Takeda) - Decarbonization
Devin Carsdale (Bristol Myers Squibb) - Decarbonization
Andrea Fasano (Pfizer) - Environment
Vincent Mignone (Kevenue) - Environment
Pamela Cornes (Johnson & Johnson) - Human Rights
Tanya Murphy (AstraZeneca) - Human Rights
Matthew Thomas (AstraZeneca) - Industrial Hygiene
Sarah Jones (Pfizer) - Industrial Hygiene
Dr JVN Reddy (Aurobindo) โ PIE & AMR
Reinhold Maeck (Boehringer Ingelheim) - PIE & AMR
Vijaya Kumar Bendi (Johnson & Johnson) - Process Safety
Germano D'Arasmo (Gilead) โ Safety
China: Gary Lu (AstraZeneca) and Li Liu (Boehringer Ingelheim)
India: Aditya Shirodkar (Abbott) and Rohit Virmani (GSK)
Lucy Latham: Chair
Lucy Latham, Global Procurement Head of ESG at Sandoz, will take on the role of Chair of the PSCI Board. Lucy brings over 15 years of expertise in procurement, sustainability, and compliance, with notable roles at Roche, GSK, Thales, and Rolls-Royce. Within the PSCI, Lucy spent 2025 as Vice Chair and was previously co-lead of the Decarbonization Topic Team.
Peter Nestor: Vice Chair
Peter Nestor, Head of Human Rights at Novartis, has been appointed Vice Chair. Within the PSCI, Peter has been active as the past Co-Lead of the Human Rights Topic Team, and now leads the Training Sub-team, building Member capability in this critical area. He is also active on Human Rights projects, including shared engagement with rightsholders and stakeholders and grievance mechanisms.
Daniel Rehm: Treasurer
Daniel Rehm, Operations Manager EEM Global API at Elanco Animal Health Inc., continues his role as Treasurer. Daniel has over 26 years of experience in process development, Health, Safety and Environment, and manufacturing. Daniel has been a dedicated PSCI member since 2016, leading the Process Safety Management Topic Team and co-leading the Capability Committee.
Li Liu: Treasurer
Li Liu, EHS Manager and Global Lead Auditor at Boehringer Ingelheim, will take on the role of PSCI Board Treasurer alongside 2025-2027 Treasurer Daniel Rehm. With 19 years of experience across R&D, operations, and EHS management, Li brings deep expertise in regulatory compliance, auditing, and sustainability. Li has been an active contributor to the PSCI in China for over a decade, serving as Co-lead of the China Regional Team.
Vincent Mignone: Secretary
Vincent Mignone, Senior Manager and EHS professional at Kenvue, has been appointed Secretary. Vincent brings deep expertise in environmental remediation, product stewardship, and sustainability, and is known for his pragmatic approach and commitment to continuous learning. He champions Kenvueโs engagement with the PSCI and was previously Co-Lead of the Environment Topic Team.
Warren Bird: Secretary
Warren Bird, Associate Director in Due Diligence & External Manufacturing at Merck (MSD), joins the Board for a two-year term as Secretary, succeeding James Lee who departed Moderna mid-term. At Merck (MSD), Warren leads EHS assessments of suppliers and supports due diligence and product development to ensure compliance with Merckโs Business Partner Code of Conduct, which aligns with the PSCI Principles.
The PSCI congratulates Lucy, Peter, Daniel, Li, Vincent, and Warren on their roles and looks forward to continued progress under their leadership.
We would also like to extend our heartfelt thanks to outgoing Board Members for their service:
Deirdre O'Reilly completed her term as Past Chair, leaving behind a lasting legacy including establishing both the Supplier Partnership program and the Projects Committee.
Ranjana Ganguly, departing Treasurer, was instrumental in ensuring PSCIโs financial sustainability and driving the PSCIโs presence and activities in India.
Rincy Joseph, departing Secretary, provided clarity and direction to PSCIโs governance, and led strategic initiatives such as the forthcoming upgrade of the PSCIโs digital platform.
As Rob Williams transitions to Past Chair, we extend our sincere gratitude for his impactful leadership and dedication. During his tenure as Chair, Rob achieved key impacts including:
Thank you, Rob, for your remarkable service and leadership. We look forward to your continued contributions as Past Chair.
About: This webinar is presented in Japanese.
Antimicrobial Resistance (AMR) is a critical global challenge that poses serious threats to healthcare systems worldwide. This webinar provides a clear overview of the fundamentals of AMR and outline how the pharmaceutical industry should respond to this pressing issue.
It introduces the Antibiotic Manufacturing Standard developed by the AMR Industry Alliance and highlight emerging certification schemes designed to ensure responsible practices across the industry. In addition, key initiatives led by the SHIONOGI Group will be presented, illustrating the path toward sustainable healthcare.
This session offers a valuable opportunity to deepen your understanding of AMR and explore practical approaches to addressing this global concern.
Speakers
The slides used in the webinar can be accessed here.
Audience in China please access the recording here.